Bitwise Asset Management CEO Hunter Horsley announced on June 22 that the firm’s XRP exchange-traded products in the U.S. and Europe have attracted over $200 million in net inflows year-to-date. The milestone underscores sustained institutional appetite for regulated XRP investment vehicles even as the broader market faces headwinds.
The U.S. product, the Bitwise XRP ETF (often tracked under ticker 1XRP or XRP), launched on the New York Stock Exchange in late 2025 and holds spot XRP in cold storage. It currently boasts a market capitalization of $256.85 million. In Europe, the Bitwise Physical XRP ETP (GXRP) has traded on Germany’s Xetra exchange since April 2022, offering a similar physical backing structure. Together, these two funds form the core of Bitwise’s XRP suite.
Daily flow data further highlights the steady demand. On June 22 alone, the total spot XRP ETF market recorded $4.72 million in net inflows, with Bitwise’s product contributing $3.97 million. Other sessions this month saw $5.31 million (June 22), $2.15 million (June 18), $4.28 million (June 16), and a monthly high of $6.37 million on June 9. Franklin Templeton’s XRPZ led several days, including a $13.6 million single-day haul in May. Cumulatively, the global spot XRP ETF market cap has swelled beyond $722 million.
May proved a landmark month, when U.S. XRP ETFs pulled in approximately $131.94 million, the strongest monthly inflow of 2026 and more than the combined outflows seen in Bitcoin and Ethereum products during the same period. This trend highlights a shift in investor interest toward altcoin-focused exchange-traded products. Bitwise itself has benefited from broader altcoin demand, with its Hyperliquid ETF (BHYP) also capturing significant daily inflows.
The consistent flows suggest that many investors are turning to regulated wrappers for XRP exposure, even as the token faces price pressures. While ETF inflows do not guarantee price appreciation, they offer a window into where fund buyers are allocating capital and reflect confidence in the long-term viability of XRP-related products.
